Table 1 Patients’ characteristics at the ICU admission and at discharge from the ICU
From: Validation of END-of-life ScorING-system to identify the dying patient: a prospective analysis
All (n = 220) | Death (n = 47) | Survivor (n = 173) | p | |
|---|---|---|---|---|
Age (yrs) | 64.5 ± 16.8 | 66.1 ± 17.1 | 64.1 ± 16.6 | 0.12 |
Sex | 0.41 | |||
Male | 128 (58.1%) | 30 (63.8%) | 98 (56.6%) | |
Female | 92 (41.9%) | 17 (36.2%) | 75 (43.4%) | |
Race | 0.04 | |||
White | 181 (82.3%) | 34 (72.3%) | 147 (84.9%) | |
Black or African American | 12 (5.4%) | 6 (12.8%) | 6 (3.5%) | |
Other | 27 (12.3%) | 7 (14.9%) | 20 (11.6%) | |
Country of birth | 0.06 | |||
Italy | 119 (54%) | 19 (38.4%) | 101 (58.3%) | |
USA | 76 (34.3%) | 22 (46.8%) | 54 (31.1%) | |
Other | 1 (0.4%) | 0 (0%) | 1 (0.6%) | |
Admission source | 0.15 | |||
Home | 54 (24.3%) | 14 (29.8%) | 40 (23.1%) | |
Nursing home/Skilled nursing facility | 13 (5.9%) | 5 (10.6%) | 8 (4.6%) | |
Acute care facility/Outside hospital | 153 (69.8%) | 28 (59.6%) | 125 (72.3%) | |
SOFA score at ICU admission | 5.4 ± 3.4 | 8.6 ± 3.6 | 4.8 ± 2.9 | < 0.01 |
Vasoactive medication requirements at ICU admission | 30 (13.6%) | 10 (21.3%) | 20 (11.6%) | 0.09 |
PaO2/FiO2 ≤ 300 at ICU admission | 44 (20%) | 17 (36.2%) | 27 (15.6%) | < 0.01 |
Serum creatinine ≥ 2 mg/dl at ICU admission | 23 (10.5%) | 10 (21.3%) | 13 (7.5%) | 0.01 |
Serum bilirubin ≥ 2 mg/dl at ICU admission | 5 (2.3%) | 3 (6.4%) | 2 (1.1%) | 0.07 |
Length of ICU stay (days) | 10.3 ± 6.6 | 11.6 ± 6.4 | 9.9 ± 6.9 | 0.07 |
Status change in DNR/DNI/CMO | < 0.01 | |||
Yes | 55 (25.7%) | 41 (87.2%) | 14 (8.1%) | |
No | 165 (74.3%) | 6 (12.8%) | 159 (91.9%) | |
After discharge | NA | |||
Another hospital floor | 155 (89.6%) | |||
Nursing home | 2 (1.2%) | |||
Long-term ventilator assist facility | 5 (2.9%) | |||
Home | 3 (1.7%) | |||
Other | 8 (4.6%) |